On the Record · Tandem Diabetes Care

Tandem Diabetes Care acquisitions, on the record

The businesses Tandem Diabetes Care bought and sold, as its annual reports describe them, with the cash it reported paying for acquisitions each year and every deal filing since 2016.

Deals its annual reports describe

Business	Deal	When	Value
AMF Medical SA Word for word“On December 10, 2022, the Company entered into a Share Purchase Agreement (Purchase Agreement) with AMF Medical SA, a corporation organized and existing under the laws of Switzerland (AMF Medical), and its shareholders to acquire all of the registered shares of AMF Medical (Transaction).” 10-K for 2023	agreed acquisition	On December 10, 2022, the Company entered into a Share Purchase Agreement (Purchase Agreement) with AMF Medical SA	—
Capillary Biomedical, Inc. Word for word“On July 21, 2022, the Company acquired Capillary Biomedical, Inc. (Capillary Biomedical), an infusion set developer, for total cash consideration of $ 24.7 million, and the assumption of $ 4.7 million of long-term debt (see Note 7, “Debt”).” 10-K for 2023	acquisition	On July 21, 2022	total cash consideration of $ 24.7 million, and the assumption of $ 4.7 million of long-term debt

Deal filings since 2016

2026-02-27 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2025-05-23 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2024-06-18 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2024-05-16 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2024-03-11 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2023-01-23 Form 8-K, Item 2.01: Completion of Acquisition or Disposition of Assets
2022-12-13 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2021-09-17 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2020-11-23 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2020-05-15 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2019-11-19 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2019-05-22 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2019-03-18 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2019-01-23 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2018-08-03 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2018-02-09 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2018-02-07 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2018-01-03 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2017-10-13 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2017-07-27 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2017-03-23 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2017-03-08 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2016-07-01 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2016-01-12 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement

Read from Tandem Diabetes Care’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-19. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.